Because of its pivotal role in the progression of MM, HMGB1 is considered one of the most important potential targets for inhibiting tumor growth, metastasis, and drug resistance and optimizing current anti-MM treatment strategies (Table 1). Here, HMGB1 is linked to neoplasm.